Iris Pauporté
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 6
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Economic and Financial Impacts of Cancer 3
- Co-authors
- P. Fumoleau (7 shared papers)Marc Espié (6 shared papers)Gilles Romieu (7 shared papers)Alain Lortholary (5 shared papers)Jean‐Yves Pierga (5 shared papers)Andrew Kramar (2 shared papers)David Khayat (2 shared papers)Pierre Kerbrat (5 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Clinical Breast Cancer (1 paper)European Journal of Cancer (1 paper)The Breast (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Iris Pauporté
12 papers receiving 337 citations
Peers
Comparison fields: 5 of 44
- Oncology 246
- Cancer Research 78
- Radiology, Nuclear Medicine and Imaging 101
- Cardiology and Cardiovascular Medicine 55
- Pulmonary and Respiratory Medicine 33
Countries citing papers authored by Iris Pauporté
This map shows the geographic impact of Iris Pauporté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Pauporté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Pauporté more than expected).
Fields of papers citing papers by Iris Pauporté
This network shows the impact of papers produced by Iris Pauporté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Pauporté. The network helps show where Iris Pauporté may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Pauporté, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 213 | |
| 2 | 2015 | 49 | |
| 3 | 2012 | 24 | |
| 4 | 2014 | 18 | |
| 5 | 2012 | 13 | |
| 6 | 2018 | 8 | |
| 7 | 2016 | 5 | |
| 8 | 2017 | 5 | |
| 9 | 2016 | 3 | |
| 10 | 2013 | 1 | |
| 11 | 2008 | 1 | |
| 12 | 2008 | 1 | |
| 13 | 2014 | 0 |
About Iris Pauporté
Iris Pauporté is a scholar working on Oncology, Economics and Econometrics, Cancer Research, General Health Professions and Public Health, Environmental and Occupational Health, having authored 13 papers that have together received 341 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Financial Impacts of Cancer (3 papers), Breast Cancer Treatment Studies (2 papers), Ethics in Clinical Research (2 papers), Healthcare Systems and Practices (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (246 citations), Cancer Research (78 citations), Radiology, Nuclear Medicine and Imaging (101 citations), Cardiology and Cardiovascular Medicine (55 citations) and Pulmonary and Respiratory Medicine (33 citations). Iris Pauporté has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include P. Fumoleau, Marc Espié, Gilles Romieu, Alain Lortholary, Jean‐Yves Pierga, Andrew Kramar, David Khayat, Pierre Kerbrat, Thomas Bachelot and Marc Debled. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Breast Cancer, European Journal of Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.